Metolazone - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for metolazone and what is the scope of patent protection?

Metolazone is the generic ingredient in four branded drugs marketed by Gd Searle Llc, Alembic, Ani Pharms, Bayshore Pharms Llc, Chemistry Hlth, Innogenix, Mylan, Ne Rx Pharma, Renata, Roxane, Rubicon, Sandoz, Watson Labs, Chartwell Molecular, and I3 Pharms, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for metolazone. Eighteen suppliers are listed for this compound.

Sponsor	Phase
Johannes Grand	Phase 4
Ospedale Regionale di Lugano	Phase 4
Stadtspital Zürich	Phase 4

Sponsor

Phase

Johannes Grand

Phase 4

Ospedale Regionale di Lugano

Phase 4

Stadtspital Zürich

Phase 4

US Patents and Regulatory Information for metolazone

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayshore Pharms Llc	METOLAZONE	metolazone	TABLET;ORAL	214799-001	Mar 30, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ani Pharms	METOLAZONE	metolazone	TABLET;ORAL	075543-003	Dec 24, 2003		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alembic	METOLAZONE	metolazone	TABLET;ORAL	213251-003	Dec 2, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ani Pharms	METOLAZONE	metolazone	TABLET;ORAL	075543-002	Mar 1, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Gd Searle Llc	DIULO	metolazone	TABLET;ORAL	018535-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	METOLAZONE	metolazone	TABLET;ORAL	076698-001	Dec 23, 2003	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chartwell Molecular	MYKROX	metolazone	TABLET;ORAL	019532-001	Oct 30, 1987	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

TABLET;ORAL

Oct 30, 1987

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	4
Applicants:	15
NDAs:	16
Drug Master File Entries:	10
Finished Product Suppliers / Packagers:	18
Raw Ingredient (Bulk) Api Vendors:	86
Clinical Trials:	24
Patent Applications:	6,347
Drug Prices:	Drug price trends for metolazone
What excipients (inactive ingredients) are in metolazone?	metolazone excipients list
DailyMed Link:	metolazone at DailyMed

Drug Class	Thiazide-like Diuretic
Physiological Effect	Increased Diuresis

Metolazone - Generic Drug Details

What are the generic sources for metolazone and what is the scope of patent protection?

Summary for metolazone

Recent Clinical Trials for metolazone

Pharmacology for metolazone

Medical Subject Heading (MeSH) Categories for metolazone

Anatomical Therapeutic Chemical (ATC) Classes for metolazone

US Patents and Regulatory Information for metolazone

Expired US Patents for metolazone

Make Better Decisions: Try a trial or see plans & pricing